Get paper from

journal cover

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators

Circulation

Dec 8, 1998

Robert J GoldbergEugene Braunwald

Get paper from

Abstract

Although diabetes is a major risk factor for coronary heart disease (CHD), little information is available on the effects of lipid lowering in diabetic patients. We determined whether lipid-lowering treatment with pravastatin prevents recurrent cardiovascular events in diabetic patients...read more

Mentioned in this Paper

Focal Glomerulosclerosis
Obesity
Lipids
High Density Lipoprotein Measurement
Myocardial Infarction
Coronary Arteriosclerosis
Relative Risk
Subgroup A Nepoviruses
Epicholesterol
Diabetic Neuropathies
60
Paper Details
References
  • References13
  • Citations466
12
  • References13
  • Citations466
12345...

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators

Circulation

Dec 8, 1998

Robert J GoldbergEugene Braunwald

PMID: 9843456

DOI: 10.1161/01.cir.98.23.2513

Abstract

Although diabetes is a major risk factor for coronary heart disease (CHD), little information is available on the effects of lipid lowering in diabetic patients. We determined whether lipid-lowering treatment with pravastatin prevents recurrent cardiovascular events in diabetic patients...read more

Mentioned in this Paper

Focal Glomerulosclerosis
Obesity
Lipids
High Density Lipoprotein Measurement
Myocardial Infarction
60

Related Papers

Paper Details
References
  • References13
  • Citations466
12
  • References13
  • Citations466
12345...

Get paper from

/papers/cardiovascular-events-and-their-reduction-with/9843456